Ligand Pharmaceuticals Stock Price - LGND

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 107.79 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  2.97 2.83% 107.79 108.07 104.44 105.88 104.82 19:59:41
Bid Price Ask Price Spread Spread % News
98.00 130.00 32.00 24.62% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,263 366,414 $ 105.85 $ 38,784,768 322,213 84.45 - 166.52
Last Trade Time Type Quantity Stock Price Currency
16:25:06 41 $ 107.79 USD

Ligand Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.89B 17.56M $ 143.32M 5.97 3.90 16.07M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 12.00 7.90%

more financials information »

Ligand Pharmaceuticals News

Date Time Source News Article
11/12/201908:30Business WireLigand Pharmaceuticals Ranked in Deloitte’s 2019 Technology..
11/08/201916:07Edgar (US Regulatory)Quarterly Report (10-q)
11/08/201908:30Business WireLigand Presents Positive Results from Phase 1 Clinical Trial..
11/07/201908:30Business WireLigand to Participate in the Stephens 2019 Nashville..
11/05/201916:06Edgar (US Regulatory)Current Report Filing (8-k)
11/05/201916:01Business WireLigand Reports Third Quarter 2019 Financial Results
10/22/201916:01Business WireLigand to Report Third Quarter 2019 Results on November 5th

Latest LGND Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LGND Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week101.05111.25100.252108.13373,4366.746.67%
1 Month107.51113.9399.51107.74334,9100.280.26%
3 Months95.64113.9384.45101.00366,96212.1512.7%
6 Months112.67120.7684.45103.41357,844-4.88-4.33%
1 Year147.47166.5284.45115.98465,763-39.68-26.91%
3 Years109.13278.6284.45141.62359,753-1.34-1.23%
5 Years57.80278.6249.50123.47356,53649.9986.49%

Ligand Pharmaceuticals Description

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Your Recent History
NASDAQ
LGND
Ligand Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191117 07:36:30